Identification of a Candida albicans Biofilm Inhibitor
Open Access
- 1 January 2022
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in American Journal of Molecular Biology
- Vol. 12 (02), 23-29
- https://doi.org/10.4236/ajmb.2022.122003
Abstract
Candida albicans proliferates in the skin and oral cavity and is the causative agent of candida dermatitis and oral candidiasis. C. albicans is known to form biofilms on oral mucosa and denture surfaces. Formation of biofilms deteriorates the permeability of antifungal drugs, decreasing their effectiveness. Therefore, in this study, I identified a compound with inhibitory activity against C. albicans biofilm formation. Heat shock protein 90 was selected as the target protein, and a potential ligand for the same was extracted and identified as 2-(4-methylpiperazin-1-yl)cyclopentanol. C. albicans was then cultured with varying concentrations of this compound: 0 mmol/L, 0.63 mmol/l. 2.5 mmol/l, and 10 mmol/l, and biofilm formation was measured via crystal violet assay. The findings demonstrated that 2-(4-methylpiperazin-1-yl)cyclopentanol substantially inhibits biofilm formation when added at a concentration of 0.63 mmol/l or higher. It is suggested that C. albicans could be eliminated more efficiently using this compound in combination with the existing antifungal drug miconazole. Further, the compound may also be useful as a disinfectant for medical devices, such as catheters, to prevent the formation of C. albicans biofilms.Keywords
This publication has 15 references indexed in Scilit:
- Pathogenesis ofCandida albicansbiofilmPathogens and Disease, 2016
- The Role of Antifungals against Candida Biofilm in Catheter-Related CandidemiaAntibiotics, 2014
- Involvement of Heat Shock Proteins in Candida albicans Biofilm FormationMicrobial Physiology, 2013
- Candida albicanspathogenicity mechanismsVirulence, 2013
- Hyphal morphogenesis: an evolutionary perspectiveFungal Biology, 2011
- Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infectionHIV/AIDS - Research and Palliative Care, 2010
- Candida Adherence and Biofilm Formation on Oral SurfacesNippon Ishinkin Gakkai Zasshi, 2005
- Candidabiofilm: a well-designed protected environmentMedical Mycology, 2005
- Bacterial biofilms: from the Natural environment to infectious diseasesNature Reviews Microbiology, 2004
- Oropharyngeal and Esophageal Candidiasis in Immunocompromised Patients: Treatment IssuesClinical Infectious Diseases, 1998